Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Split Face Randomized Placebo Controlled Clinical Trial Investigating Juvederm Vollure for the Correction of Atrophic Facial Scarring

NCT04519515 is registered in ClinicalTrials.gov with Siperstein Dermatology as lead sponsor.

NCT NCT04519515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Split Face Randomized Placebo Controlled Clinical Trial Investigating Juvederm Vollure for the Correction of Atrophic Facial Scarring
Lead sponsor
Siperstein Dermatology
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 11, 2020
Completion date
May 1, 2023
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic scar